- Home
- PED vs ONCY Comparison
PED vs ONCY Comparison
Compare PED & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- ONCY
- Stock Information
- Founded
- PED N/A
- ONCY 1998
- Country
- PED United States
- ONCY Canada
- Employees
- PED N/A
- ONCY N/A
- Industry
- PED Oil & Gas Production
- ONCY Pharmaceuticals and Biotechnology
- Sector
- PED Energy
- ONCY Health Care
- Exchange
- PED Nasdaq
- ONCY Nasdaq
- Market Cap
- PED 48.8M
- ONCY 49.1M
- IPO Year
- PED N/A
- ONCY 1999
- Fundamental
- Price
- PED $0.65
- ONCY $0.75
- Analyst Decision
- PED Strong Buy
- ONCY Strong Buy
- Analyst Count
- PED 2
- ONCY 4
- Target Price
- PED $1.63
- ONCY $4.33
- AVG Volume (30 Days)
- PED 575.7K
- ONCY 1.2M
- Earning Date
- PED 08-13-2025
- ONCY 07-31-2025
- Dividend Yield
- PED N/A
- ONCY N/A
- EPS Growth
- PED 2248.88
- ONCY N/A
- EPS
- PED 0.19
- ONCY N/A
- Revenue
- PED $40,173,000.00
- ONCY N/A
- Revenue This Year
- PED N/A
- ONCY N/A
- Revenue Next Year
- PED $5.99
- ONCY N/A
- P/E Ratio
- PED $3.36
- ONCY N/A
- Revenue Growth
- PED 30.70
- ONCY N/A
- 52 Week Low
- PED $0.47
- ONCY $0.33
- 52 Week High
- PED $1.10
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- PED 47.22
- ONCY 73.42
- Support Level
- PED $0.64
- ONCY $0.56
- Resistance Level
- PED $0.81
- ONCY $0.80
- Average True Range (ATR)
- PED 0.05
- ONCY 0.09
- MACD
- PED -0.01
- ONCY 0.02
- Stochastic Oscillator
- PED 8.05
- ONCY 94.74
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.